Last reviewed · How we verify

NCT07048678

Evaluating the Impact of Preoperative Respiratory Exercises on Post-Surgical Pulmonary Outcomes RCT

Active, enrolled NA Last updated 2 July 2025
What this trial tests

NA trial testing preoperative respiratory exercises in Pulmonary Disease in 126 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 March 2025
Primary endpoint
1 September 2025
28 February 2026

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment126
Start date17 March 2025
Primary completion1 September 2025
Estimated completion28 February 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

40 and older, any sex, with Pulmonary Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aims to evaluate the role of preoperative respiratory exercises in reducing postoperative pulmonary complications (PPCs) such as atelectasis, pneumonia, and hypoxia, and in shortening the hospital stay in surgical patients. A total of 126 adult patients (\>40 years), scheduled for total knee or hip replacement surgeries at Horizon Hospital Lahore, will be randomly assigned into two groups: the intervention group and the control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pulmonary Disease

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07048678.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing